Literature DB >> 15567459

An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.

Xinkang Wang1, Lin Xu.   

Abstract

INTRODUCTION/
OBJECTIVES: Animal models are important tools in thrombosis research and preclinical drug development. Ferric chloride has been widely used to induce arterial thrombosis in a variety of species. However, almost all previous reports applied a very high concentration of ferric chloride (10-60%) to induce thrombus formation leading to difficulties in evaluating the efficacy of antithrombotic agents. Thus, the purpose of this study was to refine the ferric-chloride-induced thrombosis model to be better suited for thrombosis research. METHODS AND
RESULTS: Dose-dependent study was used to identify a threshold concentration of ferric chloride sufficient for consistent occlusion (as reflected by the Doppler blood flow) of the carotid artery in C57BL/6 mice. Ferric chloride concentration at or about a threshold of 2.5% was found to be sensitive to anticoagulant (e.g., heparin) and antiplatelet (e.g., clopidogrel) agents. In contrast, the vessel rapidly occluded at or above 5% ferric chloride concentration despite pretreatment with the antithrombotic agents, even at doses that exerted maximal prolongation of tail bleeding time.
CONCLUSIONS: Our study provides a simple, sensitive and highly controlled method for limiting vessel injury in mice to better detect the efficacy of antithrombotic drugs and/or evaluate therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567459     DOI: 10.1016/j.thromres.2004.07.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  45 in total

1.  Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism.

Authors:  Anping Dong; Jessica Caicedo; Sung Gu Han; Paul Mueller; Sibu Saha; Susan S Smyth; C Gary Gairola
Journal:  Thromb Res       Date:  2010-05-10       Impact factor: 3.944

2.  Nanoparticle-induced platelet aggregation and vascular thrombosis.

Authors:  Anna Radomski; Paul Jurasz; David Alonso-Escolano; Magdalena Drews; Maria Morandi; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors:  Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

4.  Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Authors:  Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

5.  Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.

Authors:  Jessica C Cardenas; A Phillip Owens; Janakiraman Krishnamurthy; Norman E Sharpless; Herbert C Whinna; Frank C Church
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-13       Impact factor: 8.311

Review 6.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

7.  Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice.

Authors:  Rita K Upmacis; Hao Shen; Lea Esther S Benguigui; Brian D Lamon; Ruba S Deeb; Katherine A Hajjar; David P Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-20       Impact factor: 4.733

8.  Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis.

Authors:  Vasile I Pavlov; Mikkel-Ole Skjoedt; Ying Siow Tan; Anne Rosbjerg; Peter Garred; Gregory L Stahl
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

9.  Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Authors:  Vasile I Pavlov; Ying S Tan; Erin E McClure; Laura R La Bonte; Chenhui Zou; William B Gorsuch; Gregory L Stahl
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

10.  Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.

Authors:  Kevin J Woollard; Sharelle Sturgeon; Jaye P F Chin-Dusting; Hatem H Salem; Shaun P Jackson
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.